Clinical Pharmacology and Toxicology Section, Israel Poison Information Center, Rambam Health Care Campus, Haifa, Israel.
Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Clin Toxicol (Phila). 2021 Jun;59(6):457-463. doi: 10.1080/15563650.2020.1823405. Epub 2020 Oct 23.
During pregnancy and breastfeeding, many women require prescription medications. Concerns about drug effects on the fetus or breastfed infant may lead to decreased adherence. Our objective was to evaluate the adherence of pregnant and breastfeeding Israeli women to prescription drugs, the information they received regarding drug safety, and the women's awareness and pattern of the use of Teratogen Information Services (TIS) in Israel.
We conducted a prospective observational cohort study among pregnant and breastfeeding women who had contacted the Israel Poison Information Center (IPIC) to consult about prescription medications. In a follow-up telephone call, we assessed adherence (defined as medication initiation by the time of the follow-up call) and the patients' recollection of the safety information given by the prescribing physician. In an additional cohort of post-partum women, we assessed their awareness about TIS in Israel.
We included 59 pregnant women (62 prescriptions), 75 breastfeeding women (80 prescriptions), and 49 postpartum women. About two-thirds of all prescriptions were for antimicrobial drugs. By the time of the follow-up call, most participants (89% of pregnant and 89% of breastfeeding women) had initiated medications. Eight (11%) breastfeeding women stopped breastfeeding their babies while using the medication. Patients reported receiving explicit and unequivocal information concerning medication safety by the prescriber for 50% and 55% of prescriptions to pregnant and breastfeeding women, respectively. 70% of postpartum women interviewed in the maternity ward were not aware of TIS in Israel.
We observed high adherence rate to prescription medication therapy among pregnant and breastfeeding women in our cohort. Only about half of the women reported receiving comprehensive drug safety information by the prescriber. Raising awareness of the importance of medication safety counseling among both physicians and patients may contribute to the quality of medical care of pregnant and breastfeeding women in Israel.
在妊娠和哺乳期,许多女性需要处方药物。对胎儿或哺乳期婴儿药物效应的担忧可能导致药物依从性降低。我们的目的是评估以色列妊娠和哺乳期妇女对处方药物的依从性、她们获得的药物安全性信息,以及这些妇女对以色列致畸信息服务(TIS)的认识和使用模式。
我们对曾致电以色列中毒信息中心(IPIC)咨询处方药物的妊娠和哺乳期妇女进行了前瞻性观察性队列研究。在后续的电话随访中,我们评估了药物依从性(定义为在随访时开始服用药物)和患者对开处方医生提供的安全性信息的记忆。在另一组产后妇女中,我们评估了她们对以色列 TIS 的认识。
我们纳入了 59 名孕妇(62 份处方)、75 名哺乳期妇女(80 份处方)和 49 名产后妇女。所有处方中约有三分之二是抗菌药物。在随访时,大多数参与者(89%的孕妇和 89%的哺乳期妇女)已经开始服用药物。8 名(11%)哺乳期妇女在使用药物时停止了母乳喂养。报告称,50%和 55%的孕妇和哺乳期妇女的处方开出处方医生提供了明确和明确的药物安全性信息。在产科病房接受访谈的 70%的产后妇女不知道以色列的 TIS。
我们观察到我们队列中妊娠和哺乳期妇女对处方药物治疗的依从性率很高。只有约一半的妇女报告说从开处方的医生那里获得了全面的药物安全性信息。提高医生和患者对药物安全咨询重要性的认识,可能有助于提高以色列妊娠和哺乳期妇女的医疗质量。